Report Detail

Chemical & Material COVID-19 Impact on Global Cancer Biomarkers, Market Insights and Forecast to 2026

  • RnM4084951
  • |
  • 30 June, 2020
  • |
  • Global
  • |
  • 113 Pages
  • |
  • QYResearch
  • |
  • Chemical & Material

1 Study Coverage

  • 1.1 Cancer Biomarkers Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Cancer Biomarkers Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Cancer Biomarkers Market Size Growth Rate by Type
    • 1.4.2 Protein Biomarkers
    • 1.4.3 Genetic Biomarkers
    • 1.4.4 Others
  • 1.5 Market by Application
    • 1.5.1 Global Cancer Biomarkers Market Size Growth Rate by Application
    • 1.5.2 Breast Cancer
    • 1.5.3 Lung Cancer
    • 1.5.4 Colorectal Cancer
    • 1.5.5 Melanoma
    • 1.5.6 Blood Cancer
    • 1.5.7 Prostate Cancer
    • 1.5.8 Ovarian Cancer
    • 1.5.9 Stomach Cancer
    • 1.5.10 Liver Cancer
  • 1.6 Coronavirus Disease 2019 (Covid-19): Cancer Biomarkers Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Cancer Biomarkers Industry
      • 1.6.1.1 Cancer Biomarkers Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Cancer Biomarkers Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Cancer Biomarkers Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Cancer Biomarkers Market Size Estimates and Forecasts
    • 2.1.1 Global Cancer Biomarkers Revenue 2015-2026
    • 2.1.2 Global Cancer Biomarkers Sales 2015-2026
  • 2.2 Cancer Biomarkers Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Cancer Biomarkers Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Cancer Biomarkers Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Cancer Biomarkers Competitor Landscape by Players

  • 3.1 Cancer Biomarkers Sales by Manufacturers
    • 3.1.1 Cancer Biomarkers Sales by Manufacturers (2015-2020)
    • 3.1.2 Cancer Biomarkers Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Cancer Biomarkers Revenue by Manufacturers
    • 3.2.1 Cancer Biomarkers Revenue by Manufacturers (2015-2020)
    • 3.2.2 Cancer Biomarkers Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Cancer Biomarkers Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Cancer Biomarkers Revenue in 2019
    • 3.2.5 Global Cancer Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Cancer Biomarkers Price by Manufacturers
  • 3.4 Cancer Biomarkers Manufacturing Base Distribution, Product Types
    • 3.4.1 Cancer Biomarkers Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Cancer Biomarkers Product Type
    • 3.4.3 Date of International Manufacturers Enter into Cancer Biomarkers Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Cancer Biomarkers Market Size by Type (2015-2020)
    • 4.1.1 Global Cancer Biomarkers Sales by Type (2015-2020)
    • 4.1.2 Global Cancer Biomarkers Revenue by Type (2015-2020)
    • 4.1.3 Cancer Biomarkers Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Cancer Biomarkers Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Cancer Biomarkers Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Cancer Biomarkers Revenue Forecast by Type (2021-2026)
    • 4.2.3 Cancer Biomarkers Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Cancer Biomarkers Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Cancer Biomarkers Market Size by Application (2015-2020)
    • 5.1.1 Global Cancer Biomarkers Sales by Application (2015-2020)
    • 5.1.2 Global Cancer Biomarkers Revenue by Application (2015-2020)
    • 5.1.3 Cancer Biomarkers Price by Application (2015-2020)
  • 5.2 Cancer Biomarkers Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Cancer Biomarkers Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Cancer Biomarkers Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Cancer Biomarkers Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Cancer Biomarkers by Country
    • 6.1.1 North America Cancer Biomarkers Sales by Country
    • 6.1.2 North America Cancer Biomarkers Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Cancer Biomarkers Market Facts & Figures by Type
  • 6.3 North America Cancer Biomarkers Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Cancer Biomarkers by Country
    • 7.1.1 Europe Cancer Biomarkers Sales by Country
    • 7.1.2 Europe Cancer Biomarkers Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Cancer Biomarkers Market Facts & Figures by Type
  • 7.3 Europe Cancer Biomarkers Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Cancer Biomarkers by Region
    • 8.1.1 Asia Pacific Cancer Biomarkers Sales by Region
    • 8.1.2 Asia Pacific Cancer Biomarkers Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Cancer Biomarkers Market Facts & Figures by Type
  • 8.3 Asia Pacific Cancer Biomarkers Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Cancer Biomarkers by Country
    • 9.1.1 Latin America Cancer Biomarkers Sales by Country
    • 9.1.2 Latin America Cancer Biomarkers Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Cancer Biomarkers Market Facts & Figures by Type
  • 9.3 Central & South America Cancer Biomarkers Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Cancer Biomarkers by Country
    • 10.1.1 Middle East and Africa Cancer Biomarkers Sales by Country
    • 10.1.2 Middle East and Africa Cancer Biomarkers Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Cancer Biomarkers Market Facts & Figures by Type
  • 10.3 Middle East and Africa Cancer Biomarkers Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Corporation Information
    • 11.1.2 Abbott Laboratories Description, Business Overview and Total Revenue
    • 11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Abbott Laboratories Cancer Biomarkers Products Offered
    • 11.1.5 Abbott Laboratories Recent Development
  • 11.2 Thermo Fisher Scientific
    • 11.2.1 Thermo Fisher Scientific Corporation Information
    • 11.2.2 Thermo Fisher Scientific Description, Business Overview and Total Revenue
    • 11.2.3 Thermo Fisher Scientific Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Thermo Fisher Scientific Cancer Biomarkers Products Offered
    • 11.2.5 Thermo Fisher Scientific Recent Development
  • 11.3 F. Hoffmann-La Roche Ltd
    • 11.3.1 F. Hoffmann-La Roche Ltd Corporation Information
    • 11.3.2 F. Hoffmann-La Roche Ltd Description, Business Overview and Total Revenue
    • 11.3.3 F. Hoffmann-La Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 F. Hoffmann-La Roche Ltd Cancer Biomarkers Products Offered
    • 11.3.5 F. Hoffmann-La Roche Ltd Recent Development
  • 11.4 Illumina,Inc.
    • 11.4.1 Illumina,Inc. Corporation Information
    • 11.4.2 Illumina,Inc. Description, Business Overview and Total Revenue
    • 11.4.3 Illumina,Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Illumina,Inc. Cancer Biomarkers Products Offered
    • 11.4.5 Illumina,Inc. Recent Development
  • 11.5 Agilent Technologies
    • 11.5.1 Agilent Technologies Corporation Information
    • 11.5.2 Agilent Technologies Description, Business Overview and Total Revenue
    • 11.5.3 Agilent Technologies Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Agilent Technologies Cancer Biomarkers Products Offered
    • 11.5.5 Agilent Technologies Recent Development
  • 11.6 Qiagen NV
    • 11.6.1 Qiagen NV Corporation Information
    • 11.6.2 Qiagen NV Description, Business Overview and Total Revenue
    • 11.6.3 Qiagen NV Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Qiagen NV Cancer Biomarkers Products Offered
    • 11.6.5 Qiagen NV Recent Development
  • 11.7 Merck & Co.
    • 11.7.1 Merck & Co. Corporation Information
    • 11.7.2 Merck & Co. Description, Business Overview and Total Revenue
    • 11.7.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Merck & Co. Cancer Biomarkers Products Offered
    • 11.7.5 Merck & Co. Recent Development
  • 11.8 Hologic,Inc.
    • 11.8.1 Hologic,Inc. Corporation Information
    • 11.8.2 Hologic,Inc. Description, Business Overview and Total Revenue
    • 11.8.3 Hologic,Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Hologic,Inc. Cancer Biomarkers Products Offered
    • 11.8.5 Hologic,Inc. Recent Development
  • 11.9 Novartis AG
    • 11.9.1 Novartis AG Corporation Information
    • 11.9.2 Novartis AG Description, Business Overview and Total Revenue
    • 11.9.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Novartis AG Cancer Biomarkers Products Offered
    • 11.9.5 Novartis AG Recent Development
  • 11.10 BioMerieux SA
    • 11.10.1 BioMerieux SA Corporation Information
    • 11.10.2 BioMerieux SA Description, Business Overview and Total Revenue
    • 11.10.3 BioMerieux SA Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 BioMerieux SA Cancer Biomarkers Products Offered
    • 11.10.5 BioMerieux SA Recent Development
  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Corporation Information
    • 11.1.2 Abbott Laboratories Description, Business Overview and Total Revenue
    • 11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Abbott Laboratories Cancer Biomarkers Products Offered
    • 11.1.5 Abbott Laboratories Recent Development
  • 11.12 Affymetrix
    • 11.12.1 Affymetrix Corporation Information
    • 11.12.2 Affymetrix Description, Business Overview and Total Revenue
    • 11.12.3 Affymetrix Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Affymetrix Products Offered
    • 11.12.5 Affymetrix Recent Development
  • 11.13 Roche Diagnostics Ltd.
    • 11.13.1 Roche Diagnostics Ltd. Corporation Information
    • 11.13.2 Roche Diagnostics Ltd. Description, Business Overview and Total Revenue
    • 11.13.3 Roche Diagnostics Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Roche Diagnostics Ltd. Products Offered
    • 11.13.5 Roche Diagnostics Ltd. Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Cancer Biomarkers Market Estimates and Projections by Region
    • 12.1.1 Global Cancer Biomarkers Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Cancer Biomarkers Revenue Forecast by Regions 2021-2026
  • 12.2 North America Cancer Biomarkers Market Size Forecast (2021-2026)
    • 12.2.1 North America: Cancer Biomarkers Sales Forecast (2021-2026)
    • 12.2.2 North America: Cancer Biomarkers Revenue Forecast (2021-2026)
    • 12.2.3 North America: Cancer Biomarkers Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Cancer Biomarkers Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Cancer Biomarkers Sales Forecast (2021-2026)
    • 12.3.2 Europe: Cancer Biomarkers Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Cancer Biomarkers Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Cancer Biomarkers Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Cancer Biomarkers Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Cancer Biomarkers Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Cancer Biomarkers Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Cancer Biomarkers Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Cancer Biomarkers Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Cancer Biomarkers Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Cancer Biomarkers Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Cancer Biomarkers Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Cancer Biomarkers Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Cancer Biomarkers Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Cancer Biomarkers Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Cancer Biomarkers Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Cancer Biomarkers Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Cancer Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Cancer Biomarkers market is segmented into
    Protein Biomarkers
    Genetic Biomarkers
    Others

    Segment by Application, the Cancer Biomarkers market is segmented into
    Breast Cancer
    Lung Cancer
    Colorectal Cancer
    Melanoma
    Blood Cancer
    Prostate Cancer
    Ovarian Cancer
    Stomach Cancer
    Liver Cancer

    Regional and Country-level Analysis
    The Cancer Biomarkers market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Cancer Biomarkers market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Cancer Biomarkers Market Share Analysis
    Cancer Biomarkers market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Biomarkers business, the date to enter into the Cancer Biomarkers market, Cancer Biomarkers product introduction, recent developments, etc.
    The major vendors covered:
    Abbott Laboratories
    Thermo Fisher Scientific
    F. Hoffmann-La Roche Ltd
    Illumina,Inc.
    Agilent Technologies
    Qiagen NV
    Merck & Co.
    Hologic,Inc.
    Novartis AG
    BioMerieux SA
    Genomic Health
    Affymetrix
    Roche Diagnostics Ltd.


    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Cancer Biomarkers. Industry analysis & Market Report on COVID-19 Impact on Global Cancer Biomarkers is a syndicated market report, published as COVID-19 Impact on Global Cancer Biomarkers, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Cancer Biomarkers market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,034.00
    4,551.00
    6,067.99
    3,309.40
    4,964.09
    6,618.79
    407,191.20
    610,786.80
    814,382.40
    286,915.20
    430,372.80
    573,830.40
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report